The acquisition of Grand Rapids’ premiere molecular diagnostics laboratory by a California-based genomics leader is expanding cutting edge clinical capabilities in West Michigan. Earlier estimates indicate some 500 jobs could be on the horizon.
According to excerpts from the story:
Sequenom of San Diego has completed its previously announced acquisition of Grand Rapids-based Center for Molecular Medicine, the certified clinical diagnostics laboratory that Spectrum Health and the Van Andel Research Institute founded two years ago.
As part of the acquisition, Sequenom has formalized certain collaborative agreements with Spectrum and the VARI. The laboratory has been renamed the Sequenom Center for Molecular Medicine. The advanced molecular pathology laboratory offers cutting-edge diagnostics, translational research and clinical trials.
Its diagnostic services include robotic DNA and RNA extraction, DNA microarrays, multiplex protein detection, gene expression profiling and others. It combines the clinical resources of Spectrum Health with VARI’s translation
Read the complete story here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.